Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
7 studies found for:    Bronchiectasis | Open Studies | NIH, U.S. Fed

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Cross-sectional Characterization of Idiopathic Bronchiectasis
Condition: Infection
Intervention:
2 Recruiting Natural History of Bronchiectasis
Conditions: Bronchiectasis;   Cystic Fibrosis;   Autoimmune Disease;   Common Variable Immunodeficiency
Intervention:
3 Unknown † A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Conditions: Asthma;   Bronchiectasis
Interventions: Drug: DAS181 dry powder, formulation F02;   Drug: Respitose ML006 (DMV-Fonterra)
4 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
Intervention:
5 Recruiting Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
Intervention:
6 Recruiting Genetics of Primary Ciliary Dyskinesia
Conditions: Primary Ciliary Dyskinesia;   Kartagener Syndrome
Intervention:
7 Recruiting Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease
Condition: Kartagener Syndrome
Intervention:
To Top

† Indicates status has not been verified in more than two years